Source: Eur Respir J 2001; 18: 748-752
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Hirano K., Sakamoto T., Uchida Y., Morishima Y., Masuyama K., Ishii Y., Nomura A., Ohtsuka M., Sekizawa K.. Tissue inhibitor of metalloproteinases-;2 gene polymorphisms in chronic obstructive pulmonary disease. Eur Respir J 2001; 18: 748-752

Member's Comments

No comment yet.

Related content which might interest you: Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 521s Year: 2001 Angiotensin-converting-enzyme gene polymorphism and susceptibility to chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 195s Year: 2002 Matrix metalloproteinases and lung disease severity in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 249s Year: 2001 Genetic polymorphisms in MMP9 and TIMP2 genes and risk of chronic obstructive pulmonary disease Source: Annual Congress 2009 - Genetics in the smokers corner: from inflammation in smokers via COPD to cancer Year: 2009 Polymorphism of the cyclo-oxygenase-2 gene protects against the development of chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 439s Year: 2005 Genetic susceptibility to chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=84 Year: 2006 To correlate of the NOS1 C/T polymorphism with the activity of proteases and antiproteases in the serum and sputum in chronic obstructive pulmonary disease patients Source: Eur Respir J 2006; 28: Suppl. 50, 585s Year: 2006 Effect of phosphodiesterase 5 inhibitor in patients with pulmonary hypertension associated with chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Therapy of pulmonary hypertension Year: 2021 Characterization of elastin degradation biomarkers in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Polymorphism of NRAMP1 gene in chronic obstructive pulmonary disease patients Source: Eur Respir J 2004; 24: Suppl. 48, 315s Year: 2004 Polymorphism of collagen I gene and glutation-S-transferases T1 and M1 in chronic obstructive pulmonary disease associated with cardiovascular disease Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients Source: Eur Respir J 2008; 32: 372-378 Year: 2008 Desmosin as a marker for tissue injury in COPD Source: Annual Congress 2007 - α1-Antitrypsin deficiency: molecular and clinical news Year: 2007 Elastin expression in very severe human COPD Source: Eur Respir J 2009; 33: 324-331 Year: 2009 Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive lung disease Source: Eur Respir J 2003; 22: Suppl. 45, 20s Year: 2003 Expression of matrix metalloproteinases and TIMP inhibitors in circulation/lung in patients with chronic obstructive pulmonary disease Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012 Proteinase 3 activity in sputum from subjects with alpha-1-antitrypsin deficiency and COPD Source: Eur Respir J 2013; 41: 1042-1050 Year: 2013 The role of matrix metalloproteinase-9 in the formation of chronic obstructive pulmonary disease associated with coronary heart disease Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 Increased rho-kinase activity is related to pulmonary endothelial dysfunction in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008 Variability in expression of aquoporine 1 in chronic obstructive pulmonary disease and interstitial lung disease patients Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009